尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Reich Samuel J, 首席财务官. Insider active across 2 companies, notably Big Cypress Acquisition Corp.. In total, 3 disclosures have been logged. Split: 2 buys · 0 sell. Total volume traded: €18k. History available since 14 October 2021. The latest transaction was disclosed on 29 November 2023 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Samuel J. Reich is the Chief Financial Officer, Chairman, and CEO of Big Cypress Acquisition Corp. and SAB Biotherapeutics, Inc. He is responsible for the financial management of both companies, ensuring compliance and financial strategy. His expertise is essential in ensuring the financial health of the organizations.